Open Access

Non-vitamin K antagonist oral anticoagulants in cardioversion: the ENSURE-AF study.

Congress Session

About the speaker

Professor Andreas Goette

Saint Vincenz Hospital Paderborn, Paderborn (Germany)
33 presentations
0 follower

5 more presentations in this session

Welcome and introduction - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

Speaker: Doctor J. Weitz (Hamilton, CA)

Thumbnail

Update from ENGAGE AF-TIMI 48: clinical implications.

Speaker: Doctor R. Giugliano (Boston, US)

Thumbnail

Management of atrial fibrillation: the new European Society of Cardiology 2016 Guidelines.

Speaker: Professor H. Heidbuchel (Edegem, BE)

Thumbnail

Panel discussion - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

Speaker: Doctor J. Weitz (Hamilton, CA) Professor G. Lip (Liverpool, GB) Doctor R. Giugliano (Boston, US) Professor A. Goette (Paderborn, DE) Professor H. Heidbuchel (Edegem, BE)

Thumbnail

Summary and key messages - Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications.

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Access the full session

Expanding current insights of non-vitamin K antagonist oral anticoagulants in atrial fibrillation: clinical implications

Speakers: Professor A. Goette, Doctor J. Weitz, Doctor R. Giugliano, Professor H. Heidbuchel, Doctor J. Weitz...
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

Related content

Open Access

Management of ASCVD risk in apparently healthy people.

30 August 2021

ESC Premium Access

Prognostic value of ABCDE stress echocardiography

27 August 2021

Open Access

Optimizing SGLT2 inhibition: recent data.

29 June 2021

This platform is supported by

logo Novo Nordisk